Tirzepatide is a peptide that acts as a dual agonist, targeting both the GIP and GLP-1 receptors. It is studied in metabolic research and supplied as a reference compound for research use only.
What dual agonist means
Where a single agonist like Semaglutide interacts with one target, Tirzepatide is designed to interact with two: the GIP receptor and the GLP-1 receptor. That is what places it a step beyond the single-agonist members of the GLP-1 family.
How it is studied
In the laboratory, Tirzepatide is studied in metabolic research. The research-grade compound is a study tool, not a therapeutic, and like any research peptide it is supplied for research use only.
Browse research-grade peptides
Every Axis compound is third-party tested to 99.4%+ purity, with a certificate of analysis on every batch.
What to look for
A research-grade compound should ship with a batch-specific certificate of analysis documenting purity and identity. For a direct comparison, see Semaglutide vs. Tirzepatide.
Key takeaways
- Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide.
- It targets two receptors, unlike single agonists.
- It is studied in metabolic research.
- Research-grade Tirzepatide is supplied for research use only.
A note on research use
The peptides supplied by Axis Peptide Labs are reference compounds for laboratory and research use only. They are intended for qualified researchers working in academic, institutional, and analytical settings. They are not drugs, foods, cosmetics, or medical products, and they are not intended for human or veterinary consumption. Documented identity and documented purity are what matter most when sourcing a compound, both of which are published on the Axis certificates of analysis page.
